LVTX
LAVA Therapeutics N.V.
$1.56
+$0.07(+5.05%)
58
Overall
--
Value
58
Tech
--
Quality
Market Cap
$39.72M
Volume
278.06K
52W Range
$0.85 - $2.09
Target Price
$1.37
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Total Revenue | $5.0M | $19.4M | $6.8M | $12.0M | ||
| Total Revenue | $5.0M | $19.4M | $6.8M | $12.0M | ||
| COST OF GOODS SOLD | ||||||
| Cost of Revenue | -- | $-54.2M | $3.5M | -- | ||
| GROSS PROFIT | ||||||
| Gross Profit | $5.0M | $19.4M | $3.3M | $12.0M | ||
| OPERATING EXPENSES | ||||||
| Operating Expenses | $49.4M | $54.2M | $46.5M | $41.7M | ||
| Research & Development | $37.2M | $40.1M | $25.5M | $28.4M | ||
| Research Expense | $37.2M | $40.1M | $25.5M | $28.4M | ||
| Selling, General & Administrative | $12.2M | $14.1M | $2.7M | $13.2M | ||
| General & Administrative Expenses | $12.2M | $14.1M | $2.7M | $13.2M | ||
| Salaries & Wages | $-4.3M | -- | $18.3M | $3.2M | ||
| Depreciation & Amortization | $-227.0K | $-277.0K | -- | $500.0K | ||
| Depreciation & Amortization | $-227.0K | $-277.0K | -- | $500.0K | ||
| Other Operating Expenses | -- | -- | -- | $574.0K | ||
| OPERATING INCOME | ||||||
| Operating income | $-44.4M | $-34.8M | $-43.3M | $-29.7M | ||
| EBITDA | $-44.9M | $-30.8M | $-42.1M | $-23.5M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $-625.0K | $82.0K | $232.0K | $515.0K | ||
| Intinc | -- | -- | $3.2M | $3.8M | ||
| Net Non-Operating Interest Income/Expense | $625.0K | $-257.0K | $3.0M | $3.8M | ||
| Other Income/Expense | $6.2M | $2.9M | $-1.4M | -- | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-45.2M | $-31.6M | $-41.5M | $-24.0M | ||
| Pre-Tax Income | $-45.2M | $-31.7M | $-41.7M | $-24.5M | ||
| INCOME TAX | ||||||
| Tax Provision | $157.0K | $249.0K | $279.0K | $630.0K | ||
| NET INCOME | ||||||
| Net Income | $-51.6M | $-31.9M | $-42.0M | $-25.1M | ||
| Net Income (Continuing Operations) | $-51.6M | $-31.9M | $-42.0M | $-25.1M | ||
| Net Income (Discontinued Operations) | $-51.6M | $-31.9M | $-42.0M | $-25.1M | ||
| Net Income (Common Stockholders) | $-51.6M | $-31.9M | $-42.0M | $-25.1M | ||
| Normalized Income | -- | -- | $-30.6M | -- | ||
| TOTALS | ||||||
| Total Expenses | $49.4M | $54.2M | $50.0M | $41.7M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $19.8M | $25.9M | $26.7M | $26.8M | ||
| Average Shares Outstanding (Diluted) | $22.6M | $31.4M | $26.7M | $26.8M | ||
| Shares Outstanding | $25.8M | $26.3M | $26.3M | $26.3M | ||
| Basic EPS | $-2.3 | $-1.23 | $-1.57 | $-0.94 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-1.57 | $-0.94 | ||
| Diluted EPS | $-2.28 | $-1.23 | $-1.57 | $-0.94 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-1.57 | $-0.94 | ||
| OTHER METRICS | ||||||
| Earnings from equity interest | $-6.2M | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $-6.2M | -- | -- | -- | ||
| Insurance And Claims | -- | -- | $2.7M | -- | ||
| Interest Expense Operating | $625.0K | $-257.0K | -- | -- | ||
| Other Costof Revenue | -- | -- | $3.5M | -- | ||
| Other Gand A | $12.2M | $14.1M | $2.7M | $13.2M | ||
| Rent And Landing Fees | $12.2M | $14.1M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LVTX | $1.56 | +5.1% | 278.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |